UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 5)
Omega Healthcare Investors, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.10 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
681936100
------------------------------------------------------
(CUSIP Number)
Kym Irvin
Explorer Holdings, L.P.
2200 Ross Avenue
Suite 4200 West
Dallas, Texas 75201-6799
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
February 21, 2002
-------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the reporting person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|.
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
to whom copies are to be sent.
Page 1 of 9
----------------------------- -----------------------
CUSIP NO. 681936100 13D Page 2 of 9 Pages
----------------------------- -----------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Explorer Holdings, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |X|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
-----------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 28,049,226**
OWNED BY -----------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH None
-----------------------------------------------------
10 SHARED DISPOSITIVE POWER
28,049,226**
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
28,049,226**
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES |_|*
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
52.0%**
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
**The Reporting Person beneficially owns 11,274,506 shares of common stock and
1,048,420 shares of Series C Convertible Preferred Stock, which Series C shares
are convertible into 16,774,720 shares of common stock of Omega. Based on the
number of shares of common stock of Omega reported to be outstanding as of
January 24, 2002, all such shares would represent 52.0% of Omega's outstanding
shares of common stock, after giving effect to the conversion of the Series C
Preferred and the issuance of common stock pursuant to the rights offering
completed by Omega on February 21, 2002.
----------------------------- -----------------------
CUSIP NO. 681936100 13D Page 3 of 9 Pages
----------------------------- -----------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Explorer Holdings GenPar, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |X|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
-----------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 28,049,226**
OWNED BY -----------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH None
-----------------------------------------------------
10 SHARED DISPOSITIVE POWER
28,049,226**
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
28,049,226**
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES |_|*
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
52.0%**
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
**See footnote ** on page 2 of this Schedule 13D/A.
----------------------------- -----------------------
CUSIP NO. 681936100 13D Page 4 of 9 Pages
----------------------------- -----------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Hampstead Investment Partners III, L.P.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |X|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
-----------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 28,049,226**
OWNED BY -----------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH None
-----------------------------------------------------
10 SHARED DISPOSITIVE POWER
28,049,226**
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
28,049,226**
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES |_|*
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
52.0%**
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
**See footnote ** on page 2 of this Schedule 13D/A.
----------------------------- -----------------------
CUSIP NO. 681936100 13D Page 5 of 9 Pages
----------------------------- -----------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Donald J. McNamara
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |X|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
-----------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 28,049,226**
OWNED BY -----------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH None
-----------------------------------------------------
10 SHARED DISPOSITIVE POWER
28,049,226**
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
28,049,226**
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES |_|*
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
52.0%**
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
**See footnote ** on page 2 of this Schedule 13D/A.
----------------------------- -----------------------
CUSIP NO. 681936100 13D Page 6 of 9 Pages
----------------------------- -----------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Daniel A. Decker
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |X|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
-----------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 28,049,226**
OWNED BY -----------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH None
-----------------------------------------------------
10 SHARED DISPOSITIVE POWER
28,049,226**
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
28,049,226**
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES |_|*
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
52.0%**
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
**See footnote ** on page 2 of this Schedule 13D/A.
This amendment amends and supplements the information set forth in the
Statement on Schedule 13D filed on May 25, 2000, as amended on April 19, 2001,
September 20, 2001, October 29, 2001 and November 26, 2001 (as amended, the
"Statement") by the Reporting Persons.
ITEM 1. SECURITY AND ISSUER.
This amendment relates to the common stock, par value $0.10 (the
"Common Stock"), of Omega Healthcare Investors, Inc. (the "Company").
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
Item 3 is hereby amended to add the following at the end thereof:
On February 21, 2002, Explorer and the Company consummated the
transactions contemplated by the Investment Agreement, as described in Amendment
No. 3 to the Statement. In accordance with the Investment Agreement, the
Reporting Persons purchased 10,720,656 shares of Common Stock for $31,304,315
and entered into an Amended and Restated Stockholders Agreement and an Amended
and Restated Registration Rights Agreement, as described in Amendment No. 3 to
the Statement. The source of funds for Explorer's purchase of shares of Common
Stock was the Reporting Persons' working capital, which was derived from capital
contributions from its partners.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
Item 5(a) is hereby amended to read in its entirety as follows:
(a) Each of the Reporting Persons beneficially owns 28,049,226 shares of
Common Stock, an amount which includes 16,774,720 shares of Common
Stock owned by virtue of Explorer's ownership of 1,048,420 shares of
Series C Preferred. Based on the number of shares of Common Stock
reported to be outstanding as of January 24, 2002, such shares would
represent 52.0% of the Company's outstanding shares of Common Stock,
after giving effect to the conversion of the Series C Preferred and the
issuance of common stock pursuant to the rights offering completed by
the Company on February 21, 2002. Explorer beneficially owns such
shares directly and each of the other Reporting Persons beneficially
own such shares indirectly through the relationships described in the
Statement. Messrs. McNamara and Decker disclaim beneficial ownership
of all shares held by Explorer.
Item 5(c) is hereby amended to read in its entirety as follows:
(c) The response to Item 3 is incorporated by reference.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Exhibits D and E to Amendment No. 3 to the Statement are amended and restated
by Exhibits A and B attached hereto.
Exhibit A - Amended and Restated Stockholders Agreement
Exhibit B - Amended and Restated Registration Rights Agreement
Exhibit C - Power of Attorney for Donald J. McNamara
Exhibit D - Power of Attorney for Daniel A. Decker
Page 7 of 9
SIGNATURES
After reasonable inquiry and to the best of the undersigned's knowledge
and belief, the undersigned certify that the information set forth in this
Statement is true, complete and correct, and agree that this Statement may be
filed collectively on behalf of each of the undersigned by Explorer Holdings,
L.P., Explorer Holdings GenPar, LLC, Hampstead Investment Partners III, L.P.,
Donald J. McNamara and Daniel A. Decker.
Date: February 22, 2002 EXPLORER HOLDINGS, L.P.
By: Explorer Holdings GenPar, LLC,
its General Partner
By: /s/ Kymberlyn J. Irvin
----------------------------------------
Kymberlyn J. Irvin
Authorized Officer
EXPLORER HOLDINGS GENPAR, LLC
By: /s/ Kymberlyn J. Irvin
----------------------------------------
Kymberlyn J. Irvin
Authorized Officer
HAMPSTEAD INVESTMENT PARTNERS III, L.P.
By: Hampstead Investment Partners III
GenPar, L.P., its General Partner
By: Hampstead GenPar III, LLC,
its General Partner
By: /s/ Kymberlyn J. Irvin
-------------------------------
Kymberlyn J. Irvin
Authorized Officer
/s/ Donald J. Mcnamara *
-----------------------------------------
Donald J. McNamara
/s/ Daniel A. Decker *
-----------------------------------------
Daniel A. Decker
--------------------
* Pursuant to Power of Attorney filed herewith.
Page 8 of 9
EXHIBIT INDEX
Exhibit A - Amended and Restated Stockholders Agreement
Exhibit B - Amended and Restated Registration Rights Agreement
Exhibit C - Power of Attorney for Donald J. McNamara
Exhibit D - Power of Attorney for Daniel A. Decker
Page 9 of 9